Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04159662

Brain Imaging of Cognition Inn Schizophrenia and Depression

Status
Recruiting
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
The Royal Ottawa Mental Health Centre · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Schizophrenia and depression are among the most disabling disorders in all of medicine. Cognitive deficits play a key role in patients' disability, affecting their capacity to contribute actively to society by sustaining employment or academic activity. Moreover, cognitive difficulties tend to persist even after the stabilization of other clinical symptoms. Verbal memory and emotion regulation are two important cognitive domains that are impaired in schizophrenia and depression and are associated with patients' functional outcomes. In this study, brain imaging is used to investigate the brain mechanisms underlying these cognitive deficits in these populations.

Detailed description

This study uses Functional Magnetic Resonance Imaging (fMRI) which is a technique that takes a 3D picture of the brain using magnetic fields. It allows researchers to estimate how active different regions of the brain are. The aim of this study is to use fMRI to better understand the cognitive problems that individuals living with schizophrenia, schizoaffective disorder, or depression experience. The study will involve three visits at The Royal's Institute of Mental Health Research in Ottawa, Canada. Each visit will last about 2.5 hours long. Visits 1 and 2: Participants are asked to fill out several questionnaires on a computer. Participants are also asked to answer some questions about their current and past mental health as well as perform some tasks involving general thinking skills. Visit 3: Participants will complete a brain scan using fMRI. Throughout the experiment, participants will perform three short tasks in the fMRI scanner. Participants will use buttons to answer some questions in response to some words and pictures.

Conditions

Timeline

Start date
2019-12-12
Primary completion
2026-10-01
Completion
2026-10-01
First posted
2019-11-12
Last updated
2026-03-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04159662. Inclusion in this directory is not an endorsement.